Heart Disease News and Research

Latest Heart Disease News and Research

Two common gene variations are associated with the risk for developing chronic kidney disease

Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.

14 Jun 2005

Invasive treatment including stenting may be more effective for heart attack patients who arrive late at hospital

Invasive treatment including stenting may have better outcomes than conventional treatments for heart attack patients who arrive at the hospital more than 12 hours after symptoms began, according to a study in the June 15 issue of JAMA.

14 Jun 2005

Fish oil does not lower risk of serious heart rhythm abnormalities for patients with implantable defibrillators

Even though previous research has shown that fatty acids from fish oil reduce the risk of sudden cardiac death, patients with implantable defibrillators who took fish oil supplements did not see a reduction in serious heart rhythm abnormalities, according to a study in the June 15 issue of JAMA: The Journal of the American Medical Association.

14 Jun 2005

Study reveals benefits of using insulin earlier

Results of an all-Canadian study announced June 13 at an international diabetes congress demonstrate that patients with type 2 diabetes can safely achieve target blood sugar (glycemic) levels faster and more frequently when insulin glargine (a basal, long-acting insulin) is added to therapy, versus using oral agents alone.

14 Jun 2005

New study supporting the importance of aggressive cholesterol-lowering

New clinical data shows that intensive cholesterol-lowering to targets below currently recommended levels significantly reduces the risk of heart attack and stroke for people with diabetes and heart disease.

14 Jun 2005

Viagra helps children with heart-lung condition achieve improved quality of life

Viagra, a drug originally developed to treat heart disease, and now more commonly used to treat impotence, may also help children with a serious heart-lung condition to walk further and breathe more easily.

14 Jun 2005

Fewer diabetics end up in hospital

According to new research from the U.S. Centers for Disease Control and Prevention (CDC), Americans with diabetes are less likely than they were a decade ago, to need hospitalization for serious complications such as kidney failure.

14 Jun 2005

Anti-cancer drug may help prevent premature births

A team from University of Newcastle upon Tyne in the UK have found that the anti-cancer drug Trichostatin A (TSA), has the potential to control early labour contractions. They are optimistic the work, which is still in the early stages, will help to reduce the 70,000 premature births in the UK each year.

14 Jun 2005

CalbaTech subsidiary files patent for stem cell delivery device

CalbaTech announced today that its wholly owned subsidiary, LifeStem has filed a U.S. Patent Application for its Stem Cell Delivery Device. The patent is for the Device and Methods for Treatment of Necrotic Tissue using Stem Cells.

14 Jun 2005

Doppler imaging provides better understanding of muscular dystrophy

A new study presented this week at the American Society of Echocardiography's 16th Annual Scientific Sessions offers new hope to children stricken with Duchene muscular dystrophy (DMD), a degenerative muscular disease characterized by a loss of voluntary muscle control which can eventually affect the heart.

14 Jun 2005

Chemokine Therapeutics granted new U.S patent

Chemokine Therapeutics has announced that it has been granted U.S. Patent No. 6,875,738 relating to the use of its anti-cancer compound, CTCE-9908, in the treatment of cancer and inhibition of angiogenesis. CTCE-9908 is designed to block CXCR4, a receptor found on the surface of cancer cells.

14 Jun 2005

Anti-cancer drug could be the first effective treatment for premature births

An anti-cancer drug could potentially be the first effective treatment for the many thousands of premature births that occur worldwide each year, scientific tests have found.

13 Jun 2005

School kids need 60 minutes or more of moderate to vigorous physical activity daily

"The take-home message for parents is that it is very important to ensure that their children spend at least an hour a day in some form of appropriate physical activity," says Dr. William B. Strong, a pediatric cardiologist and retired professor at the Medical College of Georgia who co-chaired the panel.

13 Jun 2005

Short-term use of CPAP therapy may protect against cardiovascular disease

A common sleep therapy used to treat patients with obstructive sleep apnea (OSA) may actually have a protective effect against death related to cardiovascular disease.

13 Jun 2005

Circadian clock gene also plays pivotal role in drug addiction

The gene that regulates the body's main biological clocks also may play a pivotal role in drug addiction, researchers at UT Southwestern Medical Center have found.

13 Jun 2005

Teen-age boys with type 1 diabetes showed evidence of greater atherosclerosis

Youths with type 1 diabetes, especially boys, already show early signs of cardiovascular disease by their teen-age years, according to researchers from the Keck School of Medicine of the University of Southern California and Childrens Hospital Los Angeles.

13 Jun 2005

Only 12 percent of pediatricians surveyed felt effective in treating overweight children

If North Carolina reflects what is happening nationally, most pediatricians across the country lack confidence in their ability to treat obesity, which is increasingly recognized as robbing children of physical vigor now and good health in later life, a new study shows.

13 Jun 2005

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").

12 Jun 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005

Heart Disease News and Research

Latest Heart Disease News and Research

Two common gene variations are associated with the risk for developing chronic kidney disease

Invasive treatment including stenting may be more effective for heart attack patients who arrive late at hospital

Fish oil does not lower risk of serious heart rhythm abnormalities for patients with implantable defibrillators

Study reveals benefits of using insulin earlier

New study supporting the importance of aggressive cholesterol-lowering

Viagra helps children with heart-lung condition achieve improved quality of life

Fewer diabetics end up in hospital

Anti-cancer drug may help prevent premature births

CalbaTech subsidiary files patent for stem cell delivery device

Doppler imaging provides better understanding of muscular dystrophy

Chemokine Therapeutics granted new U.S patent

Anti-cancer drug could be the first effective treatment for premature births

School kids need 60 minutes or more of moderate to vigorous physical activity daily

Short-term use of CPAP therapy may protect against cardiovascular disease

Circadian clock gene also plays pivotal role in drug addiction

Teen-age boys with type 1 diabetes showed evidence of greater atherosclerosis

Only 12 percent of pediatricians surveyed felt effective in treating overweight children

Tight glucose control lowers CVD by about 50 percent in diabetes

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Heart Disease News and Research

Latest Heart Disease News and Research

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in